FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin …
网页14 小时之前 · Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’ access to lower ...
Federal Trade Commission sues largest drug middlemen for
网页14 小时之前 · CNN —. The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
网页14 小时之前 · Sept. 20, 2024, 12:07 p.m. ET. The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit managers, accusing the drug middlemen of ...
Drug middlemen illegally drive up the cost of insulin, FTC says
网页11 小时之前 · September 20, 2024 / 3:09 PM EDT / CBS News. Federal regulators are accusing the country's three largest pharmacy benefit managers of illegally driving up the cost of insulin in the U.S., while ...
Federal Trade Commission accuses three drug middlemen of …
网页13 小时之前 · By Mirna Alsharif and Berkeley Lovelace Jr. The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices. The FTC accused the "Big ...
High insulin prices spur a federal lawsuit against three pharmacy ...
网页11 小时之前 · Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have engaged in anticompetitive practices that spur price increases, the Federal Trade Commission alleged in a lawsuit filed Friday. Pharmacy benefit managers, or PBMs, run prescription drug coverage for insurers, large ...
FTC Accuses Drug Middlemen of Inflating Insulin Prices
网页14 小时之前 · Photo: Zuma Press. The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin. The FTC on ...
FTC sues CVS, Cigna, UnitedHealth PBMs over insulin prices - STAT
网页14 小时之前 · The U.S. Federal Trade Commission filed a lawsuit against the largest pharmacy benefit managers and their group purchasing organizations for allegedly anticompetitive practices that ...
Federal Trade Commission to sue drug middlemen over prices of ...
网页2024年7月10日 · The Federal Trade Commission is planning to sue three large U.S. health companies over their practices as middlemen who negotiate prices for medications such as insulin, as the agency...
FTC sues drug 'gatekeepers' over high insulin prices - USA TODAY
网页13 小时之前 · 0:04. 1:12. The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients toward higher-priced insulin to reap ...
- 某些结果已被删除
跳至内容